Speciality Medi.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
204.50
-0.2 (-0.1%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 10000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10.0 k (28.21%) Volume

Shareholding (Mar 2026)

FII

0.24%

Held by 2 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

43.43%

Why is Speciality Medicines Ltd falling/rising?

11-Jun-2026

As of 10-Jun, the stock price of Speciality Medicines Ltd is declining, currently at Rs 204.70, reflecting a 4.79% decrease. The stock is underperforming its sector and trading below all key moving averages, indicating a bearish trend and reduced investor participation.

As of 10-Jun, the stock price of Speciality Medicines Ltd is falling, currently at Rs 204.70, which reflects a decrease of Rs 10.3 or 4.79%. This decline is evident as the stock underperformed its sector by 4.33% today and opened with a loss of 5%. Additionally, the stock reached an intraday low of Rs 204.25, indicating significant downward pressure.<BR><BR>The stock has also been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bearish trend. Furthermore, there has been a notable decline in investor participation, with delivery volume dropping by 71.75% compared to the 5-day average. This lack of engagement may contribute to the stock's falling price, as reduced trading activity can lead to lower demand and further price declines. Overall, these factors collectively explain the current downward movement in the stock price of Speciality Medicines Ltd.

View full answer

What does Speciality Medi. do?

11-Jun-2026

Speciality Medicines Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, with a market cap of INR 180 Cr. It has no reported sales or profits for the latest quarter, a P/E ratio of 14.00, and a return on equity of 18.30%.

Overview:<BR>Speciality Medicines Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>There are no details available regarding the incorporation year or any status changes. Additionally, no sales or profit data has been reported for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 180 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 14.00<BR>Industry P/E: 34<BR>Dividend Yield: 0.00%<BR>Debt-Equity: -0.25<BR>Return on Equity: 18.30%<BR>Price-to-Book: 2.65<BR><BR>Contact Details:<BR>Registrar Address: Not available.

View full answer

Which are the latest news on Speciality Medi.?

11-Jun-2026

How big is Speciality Medi.?

11-Jun-2026

As of 10th June, Speciality Medicines Ltd has a market capitalization of 180.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Speciality Medicines Ltd has a market capitalization of 180.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 30.42 Cr and Total Assets valued at 39.98 Cr.

View full answer

When is the next results date for Speciality Medicines Ltd?

22-May-2026

The next results date for Speciality Medicines Ltd is 28 May 2026.

The next results date for Speciality Medicines Ltd is scheduled for 28 May 2026.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 180 Cr (Micro Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.25

stock-summary
Return on Equity

18.30%

stock-summary
Price to Book

2.53

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Results - Financial Results For The Half Year And Year Ended March 31 2026

28-May-2026 | Source : BSE

We hereby submit Financial Results for the Half Year and Year ended March 31 2026.

Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E On May 28 2026

28-May-2026 | Source : BSE

We hereby submit the Outcome of Board Meeting held On May 28 2026.

Board Meeting Intimation for Meeting Of Board Of Directors Of Speciality Medicines Limited To Be Held On May 28 2026

21-May-2026 | Source : BSE

Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve 1. Audited Standalone Financial Statements of the company for the financial year ended on March 31 2026. 2. To consider approve and take on record Audited Standalone Financial Results of the company for the half year and the financial Year ended on March 31 2026 as per Regulation 33 of Listing Regulations. 3. Any other matter with the permission of the Chairman.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
8.05
Debt to EBITDA (avg)
0.52
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.30
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
25.44%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
14
Industry P/E
33
Price to Book Value
2.53
EV to EBIT
12.01
EV to EBITDA
11.86
EV to Capital Employed
3.04
EV to Sales
2.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
25.35%
ROE (Latest)
18.30%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Mildly Bullish
OBV
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.24%)

Promoter with highest holding

Parthkumar Babulal Goyani (21.12%)

Highest Public shareholder

Aparna Samir Thakker (7.33%)

Individual Investors Holdings

48.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Speciality Medi."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "44.78",
          "val2": "30.80",
          "chgp": "45.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.34",
          "val2": "4.41",
          "chgp": "89.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.87",
          "val2": "0.22",
          "chgp": "295.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.18",
          "val2": "2.68",
          "chgp": "205.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.62%",
          "val2": "14.32%",
          "chgp": "4.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Speciality Medi."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 29.21% vs 111.74% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 80.97% vs 145.73% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "75.29",
          "val2": "58.27",
          "chgp": "29.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.68",
          "val2": "9.09",
          "chgp": "50.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.32",
          "val2": "0.47",
          "chgp": "180.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "13.03",
          "val2": "7.20",
          "chgp": "80.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.17%",
          "val2": "15.60%",
          "chgp": "2.57%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
44.78
30.80
45.39%
Operating Profit (PBDIT) excl Other Income
8.34
4.41
89.12%
Interest
0.87
0.22
295.45%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.18
2.68
205.22%
Operating Profit Margin (Excl OI)
18.62%
14.32%
4.30%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
75.29
58.27
29.21%
Operating Profit (PBDIT) excl Other Income
13.68
9.09
50.50%
Interest
1.32
0.47
180.85%
Exceptional Items
0.00
0.00
Standalone Net Profit
13.03
7.20
80.97%
Operating Profit Margin (Excl OI)
18.17%
15.60%
2.57%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 29.21% vs 111.74% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 80.97% vs 145.73% in Mar 2025

stock-summaryCompany CV
About Speciality Medicines Ltd stock-summary
stock-summary
Speciality Medicines Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available